Marte C. Liefaard

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages.

Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages.

Journal: Immuno-oncology technology
Published: September 10, 2025

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.

Journal: Breast cancer research : BCR
Published: November 22, 2024

Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer.

Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer.

Journal: The Lancet. Digital health
Published: July 31, 2024

Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.

Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.

Journal: NPJ breast cancer
Published: July 18, 2024

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

Journal: NPJ breast cancer
Published: July 28, 2023

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.

Journal: British journal of cancer
Published: July 24, 2023

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies.

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies.

Journal: iScience
Published: March 31, 2023

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer.

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer.

Journal: Cell reports. Medicine
Published: December 21, 2022

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.

Journal: Breast cancer research : BCR
Published: November 15, 2022

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival.

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival.

Journal: Breast (Edinburgh, Scotland)
Published: June 02, 2022

Tumour-educated platelets for breast cancer detection: biological and technical insights.

Tumour-educated platelets for breast cancer detection: biological and technical insights.

Journal: British journal of cancer
Published: January 28, 2022

The Way of the Future: Personalizing Treatment Plans Through Technology.

The Way of the Future: Personalizing Treatment Plans Through Technology.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 01, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026